FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

28320003: Bactericide (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2007. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    47410017 Bactericide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    47415010 Bactericidal chemical en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    47416011 Bactericidal chemical product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    47417019 Antibacterial en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    758986010 Bactericide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    47410017 Bactericide en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    47410017 Bactericide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    47415010 Bactericidal chemical en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    47415010 Bactericidal chemical en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    47416011 Bactericidal chemical product en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    47416011 Bactericidal chemical product en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    47416011 Bactericidal chemical product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    47417019 Antibacterial en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    47417019 Antibacterial en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    758986010 Bactericide (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    758986010 Bactericide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1225872012 Bactericidal chemical agent en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Bactericide Is a Germicide false Inferred relationship Existential restriction modifier (core metadata concept)
    Bactericide Is a Anti-infective agent (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Bactericide Is a Substance with antibacterial mechanism of action (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely cefradine 50 milligram/1 milliliter conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Silver sulfadiazine 10mg/g cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Clofazimine 50 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely ciprofloxacin hydrochloride 750 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 100 milligram/1 milliliter conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely ciprofloxacin hydrochloride 250 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely ciprofloxacin hydrochloride 100 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely ciprofloxacin hydrochloride 500 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing only nitrofurantoin, macrocrystal 50 mg/1 each oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely nitrofurantoin 5 milligram/1 milliliter conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely tobramycin 3 milligram/1 milliliter conventional release eye solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Azithromycin dihydrate 1g suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Azithromycin dihydrate 1200mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely azithromycin dihydrate 600 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely azithromycin dihydrate 250 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Azithromycin dihydrate 100mg/5mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely cefpodoxime 20 milligram/1 milliliter conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Cefpodoxime proxetil 50mg/5mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely cefpodoxime proxetil 200 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Bacampicillin hydrochloride 400 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely tobramycin 3 milligram/1 gram conventional release eye ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Ciprofloxacin 2mg/mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Levofloxacin 25mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Cefadroxil 1 g oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Tetracycline 125mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Ceftazidime 2g/100mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Ceftazidime 100g/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release ear solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Ciprofloxacin 200mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Ciprofloxacin 400mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Ciprofloxacin 1200mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Levofloxacin 5mg solution (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Minocycline hydrochloride 100mg pellet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Minocycline hydrochloride 50mg pellet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Norfloxacin 0.3% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Demeclocycline hydrochloride 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Tetracycline hydrochloride 12.7mg/unit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Tetracycline hydrochloride 1%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Tetracycline hydrochloride 1% ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Cefaclor monohydrate 187mg/5 mL powder (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Cefaclor monohydrate 375mg/5 mL powder for oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Polymyxin b sulfate 100% powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 80 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 11.4 milligram/1 milliliter conventional release oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/3.5gm/10000unt ointment (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Bacitracin zinc + polymyxin b sulphate 500unt/10000unt ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide + clindamycin phosphate 50mg/10mg gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide + erythromycin 50mg/30mg gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Colistin sulfate + hydrocortisone acetate + neomycin sulfate 0ns/10mg/0ns solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/ns/10000unt ointment (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone + neomycin sulfate + polymyxin b sulphate 0.1%wv/ns/10000unt suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone + neomycin sulphate 1mg/3.5mg ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone + tobramycin 0.1%wv/0.3%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone + tobramycin 1mg/3mg ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone sodium phosphate + neomycin sulfate 1mg/3.5gm solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Erythromycin ethylsuccinate + sulfisoxazole acetyl ns/ns suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Fluorometholone + sulfacetamide sodium 0.1%wv/10%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Gentamicin sulfate + prednisolone acetate 0ns/0.6%ww ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Gentamicin sulfate + prednisolone acetate 0ns/10%vv suspension (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Gramicidin + neomycin sulfate + polymyxin b sulphate 0.025mg/1.75mg/10000unt solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/5mg/1.6mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone+neomycin sulfate+polymyxin b sulphate 10mg/5ns/10000unt suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/10000unt suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/1000unt solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone + polymyxin b 5mg/10000unt drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate 5mg/3.5mg/10000unit cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Isoniazid 150 mg and rifampicin 300 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Nitrofurantoin macrocrystal 25 mg and nitrofurantoin monohydrate 75 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Penicillin g benzathine + penicillin g procaine 300000unt/300000unt injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Polymyxin b sulfate + trimethoprim sulfate 10000unt/ns solution (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate + sulfacetamide sodium 0.2%wv/10%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely prednisolone acetate 2 milligram/1 gram and sulfacetamide sodium 100 milligram/1 gram conventional release eye ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate + sulfacetamide sodium 0.25%wv/10%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate + sulfacetamide sodium 5mg/100mg ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate + sulfacetamide sodium 5mg/100mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Sulfabenzamide + sulfacetamide + sulfathiazole 184mg/143.75mg/172.5mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Sulfabenzamide + sulfacetamide + sulfathiazole 3.7%ww/2.86%ww/3.42%ww cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Sulphamethoxazole + trimethoprim 200mg/40mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Sulfamethoxazole + trimethoprim 400mg/80mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Sulfamethoxazole + trimethoprim 800mg/160mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Ertapenem-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Ertapenem 1g powder for infusion solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing sulfanilamide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Cleocin t 10mg/ml lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Sulfasalazine 500mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Amikacin 500mg/100mL infusion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Amikacin 62.5mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Gentamicin 70mg/100mL infusion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Gentamicin 90mg/100mL infusion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Gentamicin sulfate 40mg/100mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Isotonic gentamicin sulfate 40mg/100ml injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Gentamicin sulfate 0.8mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Isotonic gentamicin sulfate 0.8mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Gentamicin sulfate 1.2mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)
    Isotonic gentamicin sulfate 1.2mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bactericide Inferred relationship Existential restriction modifier (core metadata concept)

    Start Previous Page 14 of 16 Next End

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    GB English

    US English

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start